BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18317693)

  • 1. Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.
    Polydorides AD; Perry A; Edgar MA
    J Neurooncol; 2008 Jun; 88(2):193-7. PubMed ID: 18317693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar medullomyoblastoma with melanotic tubular structures.
    Nozza P; Milanaccio C; Piatelli G; Rossi A; Raso A; Cama A; Garré ML; Pietsch T
    Pediatr Blood Cancer; 2008 Jan; 50(1):183-5. PubMed ID: 16550533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
    Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
    Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case].
    García-Bragado F; Cabello A; Guarch R; Ruiz de Azúa Y; Ezpeleta I
    Arch Neurobiol (Madr); 1990; 53(1):8-12. PubMed ID: 2203326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
    Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
    Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 7-year-old boy with midline cerebellar mass.
    Ismail A; Lamont JM; Tweddle AD; Pearson AD; Clifford SC; Ellison DW
    Brain Pathol; 2005 Jul; 15(3):261-2, 267. PubMed ID: 16196393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
    Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
    Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullomyoblastoma: case report.
    Cheema ZF; Cannon TC; Leech R; Brennan J; Adesina A; Brumback RA
    J Child Neurol; 2001 Aug; 16(8):598-9. PubMed ID: 11510933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study.
    Smith TW; Davidson RI
    Cancer; 1984 Jul; 54(2):323-32. PubMed ID: 6202392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
    Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cancer-testis antigens in recurrent pediatric brain tumors.
    Krishnadas DK; Bai F; Lucas KG
    J Neurooncol; 2015 May; 123(1):193-5. PubMed ID: 25855497
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of a human medulloblastoma cell line (BO-101) demonstrating skeletal muscle differentiation.
    Giangaspero F; Pession A; Trerè D; Badiali M; Galassi E; Ceccarelli C; Cavazzana A; Betts CM; Paolucci P; Stella M
    Tumori; 1991 Jun; 77(3):196-205. PubMed ID: 1862545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT-activated medulloblastoma with melanotic and myogenic differentiation: Report of a rare case.
    Rajeshwari M; Kakkar A; Nalwa A; Suri V; Sarkar C; Satyarthee GD; Garg A; Sharma MC
    Neuropathology; 2016 Aug; 36(4):372-5. PubMed ID: 26869281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous cerebellar primitive neuroectodermal tumor in a juvenile cynomolgus monkey (Macaca fascicularis).
    Mukaratirwa S; Rogerson P; Blanco AL; Naylor SW; Bradley A
    Toxicol Pathol; 2012 Aug; 40(6):931-4. PubMed ID: 22569584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
    Ho DM; Hsu CY; Wong TT; Ting LT; Chiang H
    Acta Neuropathol; 2000 May; 99(5):482-8. PubMed ID: 10805090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cytogenetic analysis of a cerebellar primitive neuroectodermal tumor with prominent neuronal differentiation: detection of MYCN amplification by differential polymerase chain reaction and Southern blot analysis.
    Jay V; Squire J; Zielenska M; Gerrie B; Humphreys R
    Pediatr Pathol Lab Med; 1995; 15(5):733-44. PubMed ID: 8597859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopathological analysis of primitive neuroectodermal tumors of the CNS].
    Zhang Q; Su X; Liang S
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):282-5. PubMed ID: 11244998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma with myogenic and/or melanotic differentiation does not align immunohistochemically with the genetically defined molecular subgroups.
    Gupta K; Jogunoori S; Satapathy A; Salunke P; Kumar N; Radotra BD; Vasishta RK
    Hum Pathol; 2018 May; 75():26-33. PubMed ID: 29412177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.